Please wait...
This page allows users to browse Anticancer proteins or peptides in clinical trials. The table below displays detailed information about each protein or peptide, including their sequences, associated NCT ID (clinical trial number), and the condition(s) being studied. Detailed experimental information can be viewed in the CancerPPD2 database peptide card or in the corresponding UniProt protein entry. Additionally, cross-references to DrugBank and ThPDB2 are provided for further research.
| Name of the Entry | Sequence | NCT ID | CancerPPD2 ID | Uniprot ID | Cross-References | Phase | Condition |
|---|---|---|---|---|---|---|---|
| p28 | LSTAADMQGVVTDGMASGLDKDYLKPDD | NCT01975116 | 7479 | NA | DB17241 | Phase 1 | Brain Tumor |
| p28 | LSTAADMQGVVTDGMASGLDKDYLKPDD | NCT00914914 | 7479 | NA | DB17241 | Phase 1 | Solid Tumor |
| ALRN-6924 | LTFAEYWAQLaAAAAAa | NCT03725436 | 4676 | NA | DB17285 | Phase 1 | Advanced Malignant Solid Neoplasm|Anatomic Stage III Breast Cancer |
| ALRN-6924 | LTFAEYWAQLaAAAAAa | NCT03654716 | 4676 | NA | DB17285 | Phase 1 | Leukemia|Brain Tumor|Solid Tumor|Lymphoma |
| ALRN-6924 | LTFAEYWAQLaAAAAAa | NCT02264613 | 4676 | NA | DB17285 | Phase 1| Phase 2 | Solid Tumor|Lymphoma|Peripheral T-Cell Lymphoma |
| ALRN-6924 | LTFAEYWAQLaAAAAAa | NCT05622058 | 4676 | NA | DB17285 | Phase 1 | Prevention of Chemotherapy-induced Myelosuppression |
| ALRN-6924 | LTFAEYWAQLaAAAAAa | NCT04022876 | 4676 | NA | DB17285 | Phase 1 | Non Small Cell Lung Cancer |
| ALRN-6924 | LTFAEYWAQLaAAAAAa | NCT02909972 | 4676 | NA | DB17285 | Phase 1 | Acute Myeloid Leukemia |
| LUNA18 | Not Available | NCT05012618 | 7842 | NA | NA | Phase 1 | Metastatic Solid Tumors |
| GV1001 | EARPALLTSRLRFIPK | NCT00444782 | 7308 | NA | DB12747 | Phase 1| Phase 2 | Hepatocellular Carcinoma |
| GV1001 | EARPALLTSRLRFIPK | NCT01579188 | 7308 | NA | DB12747 | Phase 3 | Inoperable Stage III Non-small Cell Lung Cancer |
| GV1001 | EARPALLTSRLRFIPK | NCT02854072 | 7308 | NA | DB12747 | Phase 3 | Pancreatic Cancer |
| Tigapotide | PGDSTRKCMDLKGNK | NCT00695851 | 4682 | NA | DB04985; Th1272 | Phase 1 | Prostate Cancer |
| Nelipepimut-S | KIFGSLAFL | NCT01570036 | 4174 | NA | DB06226 | Phase 2 | Breast Cancer |
| Nelipepimut-S | KIFGSLAFL | NCT02297698 | 4174 | NA | DB06226 | Phase 2 | Breast Cancer |
| Ozarelix | Not Available | NCT01252693 | 4695 | NA | DB12581 | Phase 2 | Prostate Cancer |
| LTX-315 | KKWWKKW-Dip-K | NCT01986426 | 3308 | NA | DB12748 | Phase 1 | Transdermally Accessible Tumours |
| Balixafortide | ACSAp(Dab)RYCYQKpPYH | NCT01837095 | 7848 | NA | DB15370 | Phase 1 | Breast Cancer |
| Balixafortide | ACSAp(Dab)RYCYQKpPYH | NCT01413568 | 7848 | NA | DB15370 | Phase 1| Phase 2 | Acute Myeloid Leukemia |
| Balixafortide | ACSAp(Dab)RYCYQKpPYH | NCT04826016 | 7848 | NA | DB15370 | Phase 1|Phase 2 | Advanced Breast Cancer |
| Balixafortide | ACSAp(Dab)RYCYQKpPYH | NCT03786094 | 7848 | NA | DB15370 | Phase 3 | Metastatic Breast Cancer|Locally Recurrent Breast Cancer |
| Balixafortide | ACSAp(Dab)RYCYQKpPYH | NCT01105403 | 7848 | NA | DB15370 | Phase 2 | Multiple Myeloma |
| TAK-448 | ywNTF(AzGly)R(Me)W | NCT01132404 | 7851 | NA | DB11975 | Phase 1|Phase 2 | Prostate Cancer |
| Dolastatin 10 | 2-[[2-(dimethylamino)-3-methylbutanoyl]amino]-N-[3-methoxy-1-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl]-N,3-dimethylbutanamide | NCT00003626 | 4644 | NA | DB12730 | Phase 2 | Prostate Cancer |
| Dolastatin 10 | 2-[[2-(dimethylamino)-3-methylbutanoyl]amino]-N-[3-methoxy-1-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl]-N,3-dimethylbutanamide | NCT00003557 | 4644 | NA | DB12730 | Phase 2 | Gall Bladder Cancer |
| Dolastatin 10 | 2-[[2-(dimethylamino)-3-methylbutanoyl]amino]-N-[3-methoxy-1-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl]-N,3-dimethylbutanamide | NCT00003693 | 4644 | NA | DB12730 | Phase 1 | Leukemia Cancer |
| Dolastatin 10 | 2-[[2-(dimethylamino)-3-methylbutanoyl]amino]-N-[3-methoxy-1-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl]-N,3-dimethylbutanamide | NCT00003677 | 4644 | NA | DB12730 | Phase 2 | Pancreatic Cancer |
| Dolastatin 10 | 2-[[2-(dimethylamino)-3-methylbutanoyl]amino]-N-[3-methoxy-1-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl]-N,3-dimethylbutanamide | NCT00003914 | 4644 | NA | DB12730 | Phase 2 | Kidney Cancer |
| Dolastatin 10 | 2-[[2-(dimethylamino)-3-methylbutanoyl]amino]-N-[3-methoxy-1-[2-[1-methoxy-2-methyl-3-oxo-3-[[2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl]-N,3-dimethylbutanamide | NCT00003778 | 4644 | NA | DB12730 | Phase 2 | Ovarian Cancer |
| Bleomycin A6 | MAKLTSAVPVLTARDVAGAVEFWTDRLGFSRDFVEDDFAGVVRDDVTLFISAVQDQVVPDNTLAWVWVRGLDELYAEWSEVVSTNFRDASGPAMTEIGEQPWGREFALRDPAGNCVHFVAEEQD | NCT01660399 | Available in Uniprot Proteins section | P17493 | DB12992 | Phase 2 | Lung Squamous Cell Cancer |
| Pegfilgrastim | MTPLGPASSLPQSFLLKCLEQVRKIQGDGAALQEKLCATYKLCHPEELVLLGHSLGIPWAPLSSCPSQALQLAGCLSQLHSGLFLYQGLLQALEGISPELGPTLDTLQLDVADFATTIWQQMEELGMAPALQPTQGAMPAFASAFQRRAGGVLVASHLQSFLEVSYRVLRHLAQP | NCT01516736 | Available in Uniprot Proteins section | P09919 | DB00019; Th1016 | Phase 3 | Breast Cancer |
| Endostatin | QPVLHLVALNTPLSGGMRGIRGADFQCFQQARAVGLSGTFRAFLSSRLQDLYSIVRRADRGSVPIVNLKDEVLSPSWDSLFSGSQGQLQPGARIFSFDGRDVLRHPAWPQKSVWHGSDPSGRRLMESYCETWRTETTGATGQASSLLSGRLLEQKAASCHNSYIVLCIENSF | NCT02104323 | 4690 | NA | DB06423; Th1356 | Phase 2 | NF2-Related Tumors |
| Endostatin | QPVLHLVALNTPLSGGMRGIRGADFQCFQQARAVGLSGTFRAFLSSRLQDLYSIVRRADRGSVPIVNLKDEVLSPSWDSLFSGSQGQLQPGARIFSFDGRDVLRHPAWPQKSVWHGSDPSGRRLMESYCETWRTETTGATGQASSLLSGRLLEQKAASCHNSYIVLCIENSF | NCT03208335 | 4690 | NA | DB06423; Th1356 | Phase 2 | Hepatocellular Carcinoma |
| Endostatin | QPVLHLVALNTPLSGGMRGIRGADFQCFQQARAVGLSGTFRAFLSSRLQDLYSIVRRADRGSVPIVNLKDEVLSPSWDSLFSGSQGQLQPGARIFSFDGRDVLRHPAWPQKSVWHGSDPSGRRLMESYCETWRTETTGATGQASSLLSGRLLEQKAASCHNSYIVLCIENSF | NCT04356118 | 4690 | NA | DB06423; Th1356 | Phase 4 | Non-Small Cell Lung Cancer |
| Endostatin | QPVLHLVALNTPLSGGMRGIRGADFQCFQQARAVGLSGTFRAFLSSRLQDLYSIVRRADRGSVPIVNLKDEVLSPSWDSLFSGSQGQLQPGARIFSFDGRDVLRHPAWPQKSVWHGSDPSGRRLMESYCETWRTETTGATGQASSLLSGRLLEQKAASCHNSYIVLCIENSF | NCT02745561 | 4690 | NA | DB06423; Th1356 | Phase 2 | Esophageal Cancer |
| Endostatin | QPVLHLVALNTPLSGGMRGIRGADFQCFQQARAVGLSGTFRAFLSSRLQDLYSIVRRADRGSVPIVNLKDEVLSPSWDSLFSGSQGQLQPGARIFSFDGRDVLRHPAWPQKSVWHGSDPSGRRLMESYCETWRTETTGATGQASSLLSGRLLEQKAASCHNSYIVLCIENSF | NCT00604435 | 4690 | NA | DB06423; Th1356 | Phase 2 | Breast Cancer |
| Endostatin | QPVLHLVALNTPLSGGMRGIRGADFQCFQQARAVGLSGTFRAFLSSRLQDLYSIVRRADRGSVPIVNLKDEVLSPSWDSLFSGSQGQLQPGARIFSFDGRDVLRHPAWPQKSVWHGSDPSGRRLMESYCETWRTETTGATGQASSLLSGRLLEQKAASCHNSYIVLCIENSF | NCT05551247 | 4690 | NA | DB06423; Th1356 | Phase 2 | Colorectal Cancer |
| Stem Bromelain | AVPQSIDWRDYGAVTSVKNQNPCGACWAFAAIATVESIYKIKKGILEPLSEQQVLDCAKGYGCKGGWEFRAFEFIISNKGVASGAIYPYKAAKGTCKTDGVPNSAYITGYARVPRNNESSMMYAVSKQPITVAVDANANFQYYKSGVFNGPCGTSLNHAVTAIGYGQDSIIYPKKWGAKWGEAGYIRMARDVSSSSGICGIAIDPLYPTLEE | NCT02340845 | Available in Uniprot Proteins section | P14518 | DB12249; Th1476 | Phase 2 | Breast Cancer, Lung Cancer, Colon Cancer, Cervical Cancer, Ovarian Cancer, Uterine Cancer |
| ADH-1 | GLKAADNDPTAPPYDSLLVFDYEGSGSTAGSLSSLNSSSSGGDQDYDYLNDWGPRFKKLADMYGGGDD | NCT00264433 | Available in Uniprot Proteins section | Q80XX1 | DB05485; Th1722 | Phase 2 | Neoplasm |
| ADH-1 | GLKAADNDPTAPPYDSLLVFDYEGSGSTAGSLSSLNSSSSGGDQDYDYLNDWGPRFKKLADMYGGGDD | NCT00421811 | Available in Uniprot Proteins section | Q80XX1 | DB05485; Th1722 | Phase 1|Phase 2 | Neoplasm |
| ADH-1 | GLKAADNDPTAPPYDSLLVFDYEGSGSTAGSLSSLNSSSSGGDQDYDYLNDWGPRFKKLADMYGGGDD | NCT01825603 | Available in Uniprot Proteins section | Q80XX1 | DB05485; Th1722 | Phase 1 | Neoplasm |
| ADH-1 | GLKAADNDPTAPPYDSLLVFDYEGSGSTAGSLSSLNSSSSGGDQDYDYLNDWGPRFKKLADMYGGGDD | NCT00265057 | Available in Uniprot Proteins section | Q80XX1 | DB05485; Th1722 | Phase 1| Phase 2 | Neoplasm |
| ADH-1 | GLKAADNDPTAPPYDSLLVFDYEGSGSTAGSLSSLNSSSSGGDQDYDYLNDWGPRFKKLADMYGGGDD | NCT00225550 | Available in Uniprot Proteins section | Q80XX1 | DB05485; Th1722 | Phase 1| Phase 2 | Neoplasm |
| ADH-1 | GLKAADNDPTAPPYDSLLVFDYEGSGSTAGSLSSLNSSSSGGDQDYDYLNDWGPRFKKLADMYGGGDD | NCT00421811 | Available in Uniprot Proteins section | Q80XX1 | DB05485; Th1722 | Phase 1 | Neoplasm |
| LL-37 | SKWQHQQDSCRKQLQGVNLTPCEKHIMEKIQGRGDDDDDDDDD | NCT02225366 | 1527 | NA | DB16532 | Phase 1| Phase 2 | Melanoma |
| SOR-C13 | KEFLHPSKVDLPR | NCT01578564 | 7847 | NA | DB15366 | Phase 1 | Advanced Solid tumors |
| CIGB-300 | GRKKRRQRRRPPQ-X-CWMSPRHLGTC | NCT01639625 | 7250 | NA | DB16464 | Phase 2 | Cervical Cancer |